Literature DB >> 25813218

Epigenetic Mechanisms Involved in Huntington's Disease Pathogenesis.

Kelly E Glajch1, Ghazaleh Sadri-Vakili.   

Abstract

Transcriptional dysregulation is an early event and may be an important pathological mechanism in Huntington's disease (HD). However, the exact process that leads to alterations in gene expression in HD is not clear. One potential mechanism underlying transcriptional abnormalities in HD may be epigenetic alterations which regulate gene expression without changing the DNA sequence. Previous work has demonstrated that epigenetic marks, such as DNA methylation and post-translational modifications of histone proteins, are significantly altered in HD cellular and animal models as well as HD patients. Furthermore, studies have shown a therapeutic role for histone deacetylase (HDAC) inhibitors in numerous HD …models. Here, we review a range of studies describing epigenetic changes in HD as well as several potential therapeutics that target aberrant epigenetic alterations in HD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25813218     DOI: 10.3233/JHD-159001

Source DB:  PubMed          Journal:  J Huntingtons Dis        ISSN: 1879-6397


  16 in total

Review 1.  Epigenetic Regulation in Neurodegenerative Diseases.

Authors:  Amit Berson; Raffaella Nativio; Shelley L Berger; Nancy M Bonini
Journal:  Trends Neurosci       Date:  2018-06-07       Impact factor: 13.837

2.  Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice.

Authors: 
Journal:  Nat Neurosci       Date:  2017-03-20       Impact factor: 24.884

3.  Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C.

Authors:  Chaohua Peng; Gaochun Zhu; Xiangqian Liu; He Li
Journal:  Neurosci Bull       Date:  2018-04-30       Impact factor: 5.203

Review 4.  Epigenetic regulation in Huntington's disease.

Authors:  Jae Wook Hyeon; Albert H Kim; Hiroko Yano
Journal:  Neurochem Int       Date:  2021-05-24       Impact factor: 4.297

Review 5.  Epigenetic Changes in Neurodegenerative Diseases.

Authors:  Min Jee Kwon; Sunhong Kim; Myeong Hoon Han; Sung Bae Lee
Journal:  Mol Cells       Date:  2016-11-18       Impact factor: 5.034

6.  The Association of VDAC with Cell Viability of PC12 Model of Huntington's Disease.

Authors:  Andonis Karachitos; Daria Grobys; Klaudia Kulczyńska; Adrian Sobusiak; Hanna Kmita
Journal:  Front Oncol       Date:  2016-11-11       Impact factor: 6.244

Review 7.  Contribution of Neuroepigenetics to Huntington's Disease.

Authors:  Laetitia Francelle; Caroline Lotz; Tiago Outeiro; Emmanuel Brouillet; Karine Merienne
Journal:  Front Hum Neurosci       Date:  2017-01-30       Impact factor: 3.169

8.  Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels.

Authors:  Steve Horvath; Peter Langfelder; Seung Kwak; Jeff Aaronson; Jim Rosinski; Thomas F Vogt; Marika Eszes; Richard L M Faull; Maurice A Curtis; Henry J Waldvogel; Oi-Wa Choi; Spencer Tung; Harry V Vinters; Giovanni Coppola; X William Yang
Journal:  Aging (Albany NY)       Date:  2016-07       Impact factor: 5.682

9.  Hippo Signaling Pathway Dysregulation in Human Huntington's Disease Brain and Neuronal Stem Cells.

Authors:  Kaly A Mueller; Kelly E Glajch; Megan N Huizenga; Remi A Wilson; Eric J Granucci; Amanda M Dios; Adelaide R Tousley; Maria Iuliano; Elizabeth Weisman; Michael J LaQuaglia; Marian DiFiglia; Kimberly Kegel-Gleason; Khashayar Vakili; Ghazaleh Sadri-Vakili
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

10.  SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene.

Authors:  Tiziana Petrozziello; Amanda M Dios; Kaly A Mueller; Christine A Vaine; William T Hendriks; Kelly E Glajch; Alexandra N Mills; Kotchaphorn Mangkalaphiban; Ellen B Penney; Naoto Ito; Cara Fernandez-Cerado; Gierold Paul A Legarda; M Salvie Velasco-Andrada; Patrick J Acuña; Mark A Ang; Edwin L Muñoz; Cid Czarina E Diesta; Regina Macalintal-Canlas; Geraldine Acuña; Nutan Sharma; Laurie J Ozelius; D Cristopher Bragg; Ghazaleh Sadri-Vakili
Journal:  PLoS One       Date:  2020-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.